By Kiku Steinfeld
Chicago, May 3 – JPMorgan Chase Financial Co. LLC priced $500,000 of autocallable contingent interest notes due Oct. 3, 2024 linked to the common stock of Moderna, Inc., according to a 424B2 filing with the Securities and Exchange Commission.
The notes are guaranteed by JPMorgan Chase & Co.
The notes pay a quarterly contingent interest payment at an annual rate of 11% if the stock closes at or above its 60% coupon barrier level on the relevant review date.
If the stock closes at or above 90% of its initial level on any quarterly review date starting March 29, 2022, the notes will be automatically called at par plus the contingent interest payment.
The payout at maturity will be par plus the final contingent interest payment if the stock finishes at or above its trigger price, 60% of its initial price.
Otherwise, investors will be fully exposed to the decline of the stock.
J.P. Morgan Securities LLC is the agent.
| Issuer: | JPMorgan Chase Financial Co. LLC
|
| Guarantor: | JPMorgan Chase & Co.
|
| Issue: | Autocallable contingent interest notes
|
| Underlying stock: | Moderna, Inc.
|
| Amount: | $500,000
|
| Maturity: | Oct. 3, 2024
|
| Coupon: | 11% annual rate, payable quarterly if stock closes at or above coupon barrier on review date for that period
|
| Price: | Par
|
| Payout at maturity: | Par plus interest payment if stock finishes at or above trigger price; otherwise, full exposure to losses of stock
|
| Call: | At par plus interest payment if stock finishes at or above 90% of initial level on quarterly review date starting March 29, 2022
|
| Initial price: | $378.90
|
| Coupon barrier level: | $227.34; 60% of initial price
|
| Trigger level: | $227.34; 60% of initial price
|
| Pricing date: | Sept. 29, 2021
|
| Settlement date: | Oct. 4, 2021
|
| Agent: | J.P. Morgan Securities LLC
|
| Fees: | 2.75%
|
| Cusip: | 48132W3H0
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
